Pfizer may announce interest in AstraZeneca purchase this week
28th Apr 2014 06:15
Within the past week Pfizer has revived its plans to acquire AstraZeneca and may make a public declaration of its interest this week, Bloomberg and the Financial Times reported. People familiar with the matter told the latter that a bid could come in at over $100bn, versus the UK group's current m
Read moreFriday broker round-up UPDATE
25th Apr 2014 09:19
African Barrick Gold: Deutsche Bank lowers target price from 310p to 300p maintaining a buy recommendation. Anglo American: Deutsche Bank cuts target price from 1530p to 1510p and reiterates a hold recommendation. ASOS: Deutsche Bank upgrades to buy with a target price of 5800p. Astra Zeneca: Deu
Read moreFriday newspaper round-up: Archbishop of Canterbury, AstraZeneca, Scotland
25th Apr 2014 07:17
The Archbishop of Canterbury joined the prime minister in a staunch defence of Christian Britain yesterday, as Nick Clegg called for an end to the link between church and state. The Most Rev Justin Welby said he had found it "quite baffling" to see the vociferous response to David Cameron's "moving"
Read moreLondon close: FTSE ends above 6,700 after strong US tech performance
24th Apr 2014 16:59
- FTSE ends 28.26 points higher at 6,703 - Easter retail sales rise - Ukraine kills militants, EU ponders Crimea sanctions techMARK 2,759.85 +0.65% FTSE 100 6,703.00 +0.42% FTSE 250 15,991.77 +0.01% The FTSE 100 closed above the key psychological barrier of 6,700, lifted by better-than-expected r
Read moreFTSE 100 movers: AstraZeneca leads after revenue beats expectations
24th Apr 2014 14:33
AstraZeneca rose on the back of better-than-expected revenue growth of three per cent in the first quarter, driven by the pharmaceutical company's diabetes franchise. Shares were up despite earnings falling more than expected. AstraZeneca's share price surged earlier this week on speculation it coul
Read moreBroker tips: AstraZeneca, Barclays, BSkyB, Hammerson
24th Apr 2014 13:09
Panmure Gordon has kept a 'hold' recommendation for AstraZeneca after a mixed first quarter from the pharmaceutical group, but said there were some 'bright lights' in the results such as its heartburn treatment Nexium. Analyst Savvas Neophytou said that Astra's portfolio performed well overall, "wi
Read moreLondon midday: Stocks at seven-week high as earnings impress
24th Apr 2014 12:07
- FTSE 100 at highest since March 6th - Apple, Facebook surge after the closing bell - AstraZeneca, Anglo American gain after updates techMARK 2,769.72 +1.01% FTSE 100 6,721.42 +0.70% FTSE 250 16,066.89 +0.48% The FTSE 100 was trading at a seven-week high on Thursday morning as stellar results fro
Read moreAstraZeneca shares on 'positive trajectory', says Panmure Gordon
24th Apr 2014 11:22
Panmure Gordon has kept a 'hold' recommendation for AstraZeneca after a mixed first quarter from the pharmaceutical group, but said there were some 'bright lights' in the results such as its heartburn treatment Nexium. AstraZeneca said that revenue totalled $6.42bn in the three months to March 31st
Read moreLondon open: FTSE 100 rises after results from Apple, Facebook
24th Apr 2014 08:31
- Apple, Facebook lift sentiment after results - FTSE 100 at highest since March 7th - Miners Anglo, ABG and Centamin rise techMARK 2,762.55 +0.74% FTSE 100 6,708.61 +0.51% FTSE 250 16,070.47 +0.51% Forecast-beating quarterly results from Wall Street heavyweights Apple and Facebook fed through to
Read moreThursday newspaper round-up: Ukraine, AstraZeneca, Scotland
24th Apr 2014 07:05
The rhetoric between Kiev and Moscow has taken a distinct turn for the worse. On Wednesday, Russia warned that any attack on its citizens in Ukraine would be considered as an attack on itself. That came as an 'anti-terrorist' operation against pro-Russian militants in the eastern part of the country
Read moreAstraZeneca beats revenue forecasts in Q1, but earnings slide
24th Apr 2014 07:04
- Revenues up three per cent, ahead of forecasts - BMS diabetes buyout boosts top line - Earnings fall more than expected Revenues at AstraZeneca were given a boost in the first quarter by the pharmaceutical company's diabetes franchise, but earnings fell by more than expected. AstraZeneca, whose
Read moreThursday preview: Investors waiting on AstraZeneca and Barclays
23rd Apr 2014 18:52
Thursday will be another big day in capital markets in London. In particular, traders will be braced for the latest first quarter earnings figures out from drugs giant AstraZeneca. Analysts at Credit Suisse are forecasting core (based on their own definition) earnings per share (EPS) of $1.22 for t
Read moreLondon close: FTSE ends slightly lower ahead of US earnings
23rd Apr 2014 16:59
- FTSE closes down 7.02 points at 6,674.74 - Focus turns to Apple and Facebook earnings - UK public sector net borrowing falls techMARK 2,742.15 +0.13% FTSE 100 6,674.74 -0.11% FTSE 250 15,989.64 -0.58% The FTSE 100 settled just slightly lower than its opening level as investors weighed corporate
Read moreFTSE 100 movers: ABF rises US expansion plans, broker upgrade
23rd Apr 2014 15:00
Associated British Foods was in the top spot on the FTSE 100 after the company announced its intention to expand its fast-growing Primark brand into the US towards the end of next year. Panmure Gordon upgraded its rating for the stock from 'hold' to 'buy'. saying: "This is sooner than we had antici
Read moreBroker tips: AB Foods, ARM, Wolseley...
23rd Apr 2014 12:59
Panmure Gordon has upgraded its rating for Associated British Foods from 'hold' to 'buy' after the company announced its intention to expand its fast-growing Primark brand into the US towards the end of next year. "This is sooner than we had anticipated, and whilst Primark will continue its measur
Read more